Our Experts

jill-linder-headshot

Jill Linder

Senior Manager, Market Research

Expertise: Payer Market Research, Biosimilars

Jill Linder is a senior manager of Market Research at MMIT. She has worked in healthcare market research for nearly 20 years, and currently leads quantitative market research projects using MMIT’s Rapid Response, Engage, Indices, and Trade products. Previously, she oversaw the development and execution of market research programs at a large academic medical center. She also spent several years at a major media company, providing research and consumer insights to healthcare clients. She earned a master’s degree in Marketing and MBA from Georgia State University, as well as a master’s in Accounting from University of Hartford.

Insights by Jill Linder

Article | February 16, 2023

How Will the Launch of Humira Biosimilars Impact Patients, Payers and IDNs?

This year’s impending launch of adalimumab biosimilars will serve as a case study for manufacturers, who will be studying the market’s response. Humira biosimilars have great potential to disrupt immunology market baskets, especially if multiple competitors employ aggressive discounting strategies.
Stay In Touch

Be the first to know about new arrivals and promotions

Reducing Risk: 5 Steps for a Fearless Launch